ArticleJournal of current ophthalmology
Scleral Rupture during Cryoretinopexy for Symptomatic Retinal Tears: A Case Series.
Article in Journal of current ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To report the clinical outcomes of patients who experienced scleral rupture following cryoretinopexy and to highlight potential risk factors, management strategies, and prognosis. Methods: This retrospective case series includes patients who developed scleral rupture during cryoretinopexy for symptomatic retinal tear(s) across multiple ophthalmology units in the United Kingdom and internationally, between September 2003 and May 2025. Data collected included patient demographics, medical and ocular history, clinical examination findings, surgical management, and postoperative outcomes. Results: Four cases of scleral perforation were included in this series. The median age was 61 years, with an equal distribution of males and females. All patients underwent scleral repair and pars plana vitrectomy (PPV) with silicone oil tamponade. Three patients achieved a final visual acuity of at least 20/25, while one patient had a final visual acuity of 20/200. None of the cases had a history of systemic disorders, while myopia was noted in three patients. Conclusions: Immediate scleral rupture repair combined with PPV and silicone oil tamponade is the preferred management approach and is associated with favorable postoperative outcomes. Comprehensive patient counseling and informed consent are crucial when planning cryoretinopexy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.